ELUCIDATION OF THE STRUCTURE AND RECEPTOR-BINDING STUDIES OF THE MAJOR PRIMARY, METABOLITE OF DIHYDROERGOTAMINE IN MAN

被引：71

作者：

MAURER, G ^{[1
]}

FRICK, W ^{[1
]}

机构：

[1] SANDOZ LTD,PRECLIN RES,CH-4002 BASEL,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 26卷 / 04期

关键词：

D O I：

10.1007/BF00542142

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：463 / 470

页数：8

共 17 条

[1] INVESTIGATION OF THE VENOCONSTRICTOR EFFECT OF 8' HYDROXYDIHYDROERGOTAMINE, THE MAIN METABOLITE OF DIHYDROERGOTAMINE, IN MAN [J].

AELLIG, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) :239-242

[2]

AELLIG WH, 1977, INT J CLIN PHARM BI, V15, P106

[3] LOW ORAL BIOAVAILABILITY OF DIHYDROERGOTAMINE AND 1ST-PASS EXTRACTION IN PATIENTS WITH ORTHOSTATIC HYPOTENSION [J].

BOBIK, A ;

JENNINGS, G ;

SKEWS, H ;

ESLER, M ;

MCLEAN, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :673-679

[4]

BURT DR, 1976, MOL PHARMACOL, V12, P800

[5]

CLOSSE A, 1980, DEV NEUROSCIENCE, V11, P463

[6]

CLOSSE A, 1983, MOL PHARM NEUROTRANS, P269

[7] H-3-SPIROPERIDOL LABELS DOPAMINE RECEPTORS IN PITUITARY AND BRAIN [J].

CREESE, I ;

SCHNEIDER, R ;

SNYDER, SH .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 46 (04) :377-381

[8] BIOAVAILABILITY OF DIHYDROERGOTAMINE IN MAN [J].

LITTLE, PJ ;

JENNINGS, GL ;

SKEWS, H ;

BOBIK, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (06) :785-790

[9] QUANTITATIVE-DETERMINATION OF CYTOCHROME-P-450 IN RAT-LIVER HOMOGENATE [J].

MATSUBARA, T ;

KOIKE, M ;

TOUCHI, A ;

TOCHINO, Y ;

SUGENO, K .

ANALYTICAL BIOCHEMISTRY, 1976, 75 (02) :596-603

[10] FATE AND DISPOSITION OF BROMOCRIPTINE IN ANIMALS AND MAN .1. STRUCTURE ELUCIDATION OF THE METABOLITES [J].

MAURER, G ;

SCHREIER, E ;

DELABORDE, S ;

LOOSLI, HR ;

NUFER, R ;

SHUKLA, AP .

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (04) :281-292

← 1 2 →